Evidence map›Paper›PMID 26747836›Full record

ArticleJournal of evidence-based complementary & alternative medicine2017

Antileishmanial Activities of Greek Juniper (Juniperus excelsa M.Bieb.) Against Leishmania major Promastigotes.

Mahmoodreza Moein, Gholamreza Hatam, Razieh Taghavi-Moghadam, Mohammad M Zarshenas

Open access · goldAbstract read
In one paragraph

Article in Journal of evidence-based complementary & alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Effect ofEthiopian journal of health sciences · 2021
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mahmoodreza MoeinMedicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Gholamreza HatamBasic Sciences in Infectious Diseases Research center, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Razieh Taghavi-MoghadamMedicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad M ZarshenasMedicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran zarm@sums.ac.ir.
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Petroleum ether, chloroform, ethyl acetate, and n-butanol fractions of Greek juniper (Juniperus excelsa M.Bieb. from the family Cupressaceae) were evaluated for antileishmanial activities against Leishmania major promastigotes compared to meglumine antimoniate (Glucantime). In vitro toxicity assay was performed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide and microplate ELISA reader. Extracts were prepared in ethanol/dimethyl sulfoxide (80/20) at 10 to 0.62 mg/mL. The standard was prepared in phosphate-buffered saline at 500 to 15.62 mg/mL. Both leaf and fruit extracts and related fractions showed strong inhibitory effects against promastigotes, significantly different from that of the standard. The leaf extract and the respective petroleum ether fraction showed maximum effectiveness compared to other fractions and also fruit extract and fractions (IC

Indexed as

JuniperusAntiprotozoal AgentsFruitInhibitory Concentration 50Leishmania majorLife Cycle StagesMeglumineMeglumine AntimoniateOrganometallic CompoundsPlant ExtractsPlant LeavesAntiprotozoal AgentsMeglumineMeglumine AntimoniateOrganometallic CompoundsPlant Extractsantileishmanial activityJuniperus excelsaLeishmania major

Identifiers

PMID26747836
PMCPMC5871199
OpenAlexW2229050872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.